Works by Balcioglu, E


Results: 20
    1
    2
    3
    4

    Lipid-based nanosystems: the next generation of cancer immune therapy.

    Published in:
    Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01574-1
    By:
    • Cheng, Ziyun;
    • Fobian, Seth-Frerich;
    • Gurrieri, Elena;
    • Amin, Mohamadreza;
    • D'Agostino, Vito Giuseppe;
    • Falahati, Mojtaba;
    • Zalba, Sara;
    • Debets, Reno;
    • Garrido, María J.;
    • Saeed, Mesha;
    • Seynhaeve, Ann L. B.;
    • Balcioglu, Hayri E.;
    • ten Hagen, Timo L. M.
    Publication type:
    Article
    5

    A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 759, doi. 10.1007/s00262-022-03250-0
    By:
    • Rijnders, Maud;
    • Robbrecht, Debbie G. J.;
    • Oostvogels, Astrid A. M.;
    • van Brakel, Mandy;
    • Boormans, Joost L.;
    • Aarts, Maureen J. B.;
    • Balcioglu, Hayri E.;
    • Hamberg, Paul;
    • Voortman, Jens;
    • Westgeest, Hans M.;
    • Lolkema, Martijn P.;
    • de Wit, Ronald;
    • van der Veldt, Astrid A. M.;
    • Debets, Reno
    Publication type:
    Article
    6

    Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25962-0
    By:
    • Hammerl, Dora;
    • Martens, John W. M.;
    • Timmermans, Mieke;
    • Smid, Marcel;
    • Trapman-Jansen, Anita M.;
    • Foekens, Renée;
    • Isaeva, Olga I.;
    • Voorwerk, Leonie;
    • Balcioglu, Hayri E.;
    • Wijers, Rebecca;
    • Nederlof, Iris;
    • Salgado, Roberto;
    • Horlings, Hugo;
    • Kok, Marleen;
    • Debets, Reno
    Publication type:
    Article
    7

    β<sub>1</sub> Integrin Inhibition Elicits a Prometastatic Switch Through the TGFβ--miR-200--ZEB Network in E-Cadherin--Positive Triple-Negative Breast Cancer.

    Published in:
    Science Signaling, 2014, v. 7, n. 312, p. 1, doi. 10.1126/scisignal.2004751
    By:
    • Truong, Hoa H.;
    • Jiangling Xiong;
    • Ghotra, Veerander P. S.;
    • Nirmala, Ella;
    • Haazen, Lizette;
    • Le Dévédec, Sylvia E.;
    • Balcioğlu, Hayri E.;
    • Shuning He;
    • Snaar-Jagalska, B. Ewa;
    • Vreugdenhil, Erno;
    • Meerman, John H. N.;
    • van de Water, Bob;
    • Danen, Erik H. J.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45714-0
    By:
    • Rijnders, Maud;
    • Nakauma-González, J. Alberto;
    • Robbrecht, Debbie G. J.;
    • Gil-Jimenez, Alberto;
    • Balcioglu, Hayri E.;
    • Oostvogels, Astrid A. M.;
    • Aarts, Maureen J. B.;
    • Boormans, Joost L.;
    • Hamberg, Paul;
    • van der Heijden, Michiel S.;
    • Szabados, Bernadett E.;
    • van Leenders, Geert J. L. H.;
    • Mehra, Niven;
    • Voortman, Jens;
    • Westgeest, Hans M.;
    • de Wit, Ronald;
    • van der Veldt, Astrid A. M.;
    • Debets, Reno;
    • Lolkema, Martijn P.
    Publication type:
    Article
    18
    19
    20